Questionnaire about the Adverse Events and Side Effects Following Botulinum Toxin A Treatment in Patients with Cerebral Palsy

Botulinum toxin A (BoNT-A) injections for treatment of spasticity in patients with cerebral palsy (CP) have been used for about two decades. The treatment is considered safe but a low frequency of adverse events (AE) has been reported. A good method to report AEs is necessary to verify the safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaszczyk, Izabela, Foumani, Nazli Poorsafar, Ljungberg, Christina, Wiberg, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663525/
https://www.ncbi.nlm.nih.gov/pubmed/26561833
http://dx.doi.org/10.3390/toxins7114645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663525/
https://www.ncbi.nlm.nih.gov/pubmed/26561833
http://dx.doi.org/10.3390/toxins7114645

Ejemplares similares